RecruitingNot ApplicableNCT06395922

Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy

Blockbuster LMA Versus Baska Mask in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial


Sponsor

Tanta University

Enrollment

140 participants

Start Date

Feb 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aimed to compare the performance and safety profiles of two supraglottic airway devices (SADs), the Blockbuster laryngeal mask airway (LMA) and the Baska Mask (BM), in patients underwent laparoscopic cholecystectomy (LC).


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria4

  • Aged 18-60 years
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I-II.
  • Scheduled for elective LC under general anesthesia.

Exclusion Criteria6

  • Anticipated difficult airway.
  • Renal dysfunction.
  • Hiatus hernia.
  • Obesity.
  • Pregnancy.
  • Patients taking rate-controlling medications, steroids, opioids, or regular antacids.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBlockbuster LMA

The LMA was inserted using the recommended technique, with the patient's head in the sniffing position. The appropriate size was selected based on body weight (size 3 for 30-50 kg, size 4 for 50-70 kg)

DEVICEBaska Mask

The BM was inserted by opening the mouth, avoiding the tongue, and negotiating the palatopharyngeal curve using the hand-tab.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06395922


Related Trials